Literature DB >> 12446175

Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model.

Dolores Vernet1, Monica G Ferrini, Eliane G Valente, Thomas R Magee, George Bou-Gharios, Jacob Rajfer, Nestor F Gonzalez-Cadavid.   

Abstract

The myofibroblast shares phenotypic features of both fibroblasts and smooth muscle cells. It plays a critical role in collagen deposition and wound healing and disappears by apoptosis when the wound is closed. Its abnormal persistence leads to hypertrophic scar formation and other fibrotic conditions. Myofibroblasts are present in the fibrotic plaque of the tunica albuginea (TA) of the penis in men with Peyronie's disease (PD), a localized fibrosis that is accompanied by a spontaneous induction of the inducible nitric oxide synthase (iNOS), also observed in the TGFbeta1-elicited, PD-like lesion in the rat model. iNOS expression counteracts fibrosis, by producing nitric oxide (NO) that reduces collagen deposition in part by neutralization of profibrotic reactive oxygen species. In this study we investigated whether fibroblast differentiation into myofibroblasts is enhanced in the human and rat PD-like plaque and in cultures of human tissue fibroblasts. We also examined whether NO reduces this cell differentiation and collagen synthesis. The myofibroblast content in the fibroblast population was measured by quantitative immunohistochemistry as the ratio between alpha-smooth muscle actin (ASMA; myofibroblast marker) and vimentin (general fibroblast marker) levels. We found that myofibroblast content was considerably increased in the human and TGFbeta1-induced rat plaques as compared to control TA. Inhibition of iNOS activity by chronic administration of L-iminoethyl-L-lysine to rats with TGFbeta1-induced TA lesion increased myofibroblast abundance and collagen I synthesis measured in plaque and TA homogenates from animals injected with a collagen I promoter construct driving the expression of beta-galactosidase. Fibroblast differentiation into myofibroblasts occurred with passage in the cell cultures from the human PD plaque, but was minimal in cultures from the TA. Induction of iNOS in PD and TA cultures with a cytokine cocktail and a NO donor, S-nitroso-N-acetyl penicillamine (SNAP), was detected by immunohistochemistry. Both treatments reduced the total number of cells and the number of ASMA positive cells, whereas only SNAP decreased collagen I immunostaining. These results support the hypotheses that myofibroblasts play a role in the development of the PD plaque and that the antifibrotic effects of NO may be mediated at least in part by the reduction of myofibroblast abundance and lead to a reduction in collagen I synthesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12446175     DOI: 10.1016/s1089-8603(02)00124-6

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  30 in total

Review 1.  Therapy of erectile dysfunction: potential future treatments.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

2.  PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT.

Authors:  Aylin N Bilgutay; Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2015-06-01

3.  [Pathophysiology of wound healing and current treatment strategies in a urological context].

Authors:  C Wicke; D Schilling; S Feyerabend; A Königsrainer; A Stenzl
Journal:  Urologe A       Date:  2007-12       Impact factor: 0.639

Review 4.  Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Nat Rev Urol       Date:  2010-03-09       Impact factor: 14.432

Review 5.  Nonsurgical treatment options in Peyronie's Disease: 2016 update.

Authors:  Raidh A Talib; Mohammed Abdulkareem Ibrahim; Önder Cangüven
Journal:  Turk J Urol       Date:  2016-12

6.  Inhibition of penile tunica albuginea myofibroblasts activity by adipose-derived stem cells.

Authors:  Hesong Jiang; Qingqiang Gao; Xiaoyan Che; Leilei Zhu; Zheng Zhang; Yun Chen; Yutian Dai
Journal:  Exp Ther Med       Date:  2017-09-21       Impact factor: 2.447

7.  The application of wrapping ureter by a pedicled gastrocolic omentum flap combined with an artificial external scaffold to prevent stoma stenosis in rabbit after ureterocutaneostomy.

Authors:  Shigeng Zhang; Fei Gao; Chong Xue; Nan Zhang; Feng Gao; Shaojiang Li; Jiaming Wen
Journal:  Int Urol Nephrol       Date:  2016-12-16       Impact factor: 2.370

8.  The transcriptional signatures of cells from the human Peyronie's disease plaque and the ability of these cells to generate a plaque in a rat model suggest potential therapeutic targets.

Authors:  Robert A Gelfand; Dolores Vernet; Istvan Kovanecz; Jacob Rajfer; Nestor F Gonzalez-Cadavid
Journal:  J Sex Med       Date:  2014-12-11       Impact factor: 3.802

9.  JunB mediates enhancer/promoter activity of COL1A2 following TGF-beta induction.

Authors:  Markella Ponticos; Clare Harvey; Tetsuro Ikeda; David Abraham; George Bou-Gharios
Journal:  Nucleic Acids Res       Date:  2009-06-26       Impact factor: 16.971

10.  Effects of sildenafil treatment on patients with Peyronie's disease and erectile dysfunction.

Authors:  U Ozturk; S Yesil; H N G Goktug; A Gucuk; C Tuygun; N C Sener; I Nalbant; M A Imamoglu
Journal:  Ir J Med Sci       Date:  2013-11-05       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.